Lively and in-depth discussions of city news, politics, science, entertainment, the arts, and more.
Hosted by Larry Mantle
Airs Weekdays 10 a.m.-12 p.m.

COVID-19 AMA: Early Experimental Vaccine, CA Cases And More




A man recieves a haircut at a barbershop that re-opened approximately two months after shutting it's doors due to the coronavirus pandemic  on May 18, 2020 in Fort Lauderdale, Florida.
A man recieves a haircut at a barbershop that re-opened approximately two months after shutting it's doors due to the coronavirus pandemic on May 18, 2020 in Fort Lauderdale, Florida.
Joe Raedle/Getty Images

Listen to story

33:43
Download this story 48MB

An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday.

The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in study volunteers who were given either a low or medium dose.

In the next phase of the study, led by the U.S. National Institutes of Health, researchers will try to determine which dose is best for a definitive experiment that they aim to start in July.

We discuss what we know of this experimental vaccine, as well as other developments in the battle against COVID-19, with our medical expert. If you have a question, call us at 866-893-5722. 

With files from the Associated Press. 

Guest: 

David Eisenman, M.D., professor of medicine and public health at UCLA; director of the university's Center for Public Health and Disasters; Associate Natural Scientist at RAND; he tweets @deisenman